A Devastating Syndrome Leads to Incredible Advancements in Medicine: What is VHL?

Link for CME Credit: https://uthscsa.edu/medicine/education/cme/pediatrics-now-podcast A Devastating Syndrome Leading to Incredible Advances in Medicine…Including a New Treatment! FACULTY: Gail Tomlinson, MD and Patricia Dahia, MD from the University of Texas Health Science Center 's Department of Pediatrics and University Health. OVERVIEW: In this episode of Pediatrics Now, host Holly Wayment discusses Von Hippel-Lindau (VHL) Syndrome with leading experts Dr. Gail Tomlinson and Dr. Patricia. This genetic disorder is characterized by the development of various tumors and cysts in different parts of the body, and linked to mutations in the VHL gene.   The conversation delves into the history and genetic mechanisms of VHL Syndrome, highlighting its rarity and complex nature. Dr. Tomlinson and Dr. Dahia provide insights into the symptoms, diagnosis, and the groundbreaking development of a new FDA-approved drug that offers hope for managing the disease's manifestations.   Pediatric Practitioner listeners will gain an understanding of how genetic research has transformed treatment options, moving towards precision medicine, and offering newfound hope for individuals with this challenging condition, and other conditions. Join us to explore the impact of precise genetic interventions and the ongoing research shaping the future of VHL Syndrome treatment.   Additional sources for this episode include The New York Times and Wikipedia.   OVERALL LEARNING OBJECTIVE: Increased awareness and education for pediatric providers DISCLOSURE TO LEARNERS: Gail Tomlinson, MD and Dr. Patricia Dahia, MD have no financial relationships with ineligible companies to disclose.   The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose. The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests. CONTINUING MEDICAL EDUCATION STATEMENTS: The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The UT Health Science Center San Antonio designates this live activity up to a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CERTIFICATE OF ATTENDANCE: Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance. Credit may be obtained upon successful completion of the activity’s evaluation. RELEASE DATE: 4/2/2025 EXPIRATION DATE: 8/31/2027